A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart
NCT00690950
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG:
Dutasteride
Sponsor
Urologic Consultants of Southeastern PA